Lonza’s Ibex Biomanufacturing Complex, Visp, Switzerland
Lonza has developed a new biomanufacturing complex at its biopark in Visp, Switzerland.
Moderna receives emergency use listing from WHO for Covid-19 vaccine
Moderna has received emergency use listing (EUL) from the World Health Organization (WHO) for its...
Roche reports 3% increase in group sales in first quarter of 2021
Roche has reported a 3% increase in group sales to $16.247bn (CHF14.9bn) in the first...
Roche’s antibody cocktail lowers hospitalisation by 70% in Covid-19 patients
Roche has reported that the Phase III REGN-COV 2067 trial of investigational antibody cocktail of...
Novartis’ canakinumab fails to meet primary endpoint in lung cancer trial
Novartis has reported that the Phase III CANOPY-2 study of canakinumab (ACZ885) in combination with...
Novartis signs Covid-19 vaccine manufacturing agreement with CureVac
Novartis has entered an initial agreement to manufacture the mRNA and bulk drug product for...
WHO panel advises against use of hydroxychloroquine to prevent Covid-19
The World Health Organization’s (WHO) Guideline Development Group (GDG) expert panel has made a recommendation...
Andrew Alliance
Andrew Alliance develops pipetting robots and systems for the pharmaceutical industry.
Moderna’s Covid-19 vaccine receives interim authorisation in Singapore
The Singapore Health Sciences Authority (HSA) has approved the interim authorisation of Moderna’s mRNA Covid-19...
GSK and CureVac enter Covid-19 vaccine development collaboration
GlaxoSmithKline (GSK) and CureVac have entered a €150m ($180m) collaboration to jointly develop mRNA vaccines...
